Gender-related differences in oxidative stress levels among elderly patients with coronary artery disease

Fertility and Sterility

Volumn 89, Issue 3, 2008, Pages 608-613

  Vassalle, Cristina ^a   Maffei, Silvia ^a   Boni, Claudio ^a   Zucchelli, Gian Carlo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

CAD; Gender differences; menopause; oxidative stress

Indexed keywords

HYDROPEROXIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; AGING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OXIDATIVE STRESS; PEROXIDES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 40249101603     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.052     Document Type: Article

References (22)

1. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
2. Kikuchi A., Takeda A., Onodera H., Kimpara T., Hisanaga K., Sato N., et al. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis 9 (2002) 244-248
3. Schuessel K., Leutner S., Cairns N.J., Muller W.E., and Eckert A. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transm 111 (2004) 1167-1182
4. Dreyer L., Prescott E., and Gyntelberg F. Association between atherosclerosis and female lung cancer-a Danish cohort study. Lung Cancer 42 (2003) 247-254
5. Kreuzer M., Gerken M., Heinrich J., Kreienbrock L., and Wichmann H.E. Hormonal factors and risk of lung cancer among women?. Int J Epidemiol 32 (2003) 263-271
6. Mollerup S., Berge G., Baera R., Skaug V., Hewer A., Phillips D.H., et al. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer 119 (2006) 741-744
7. Quyyumi A.A. Women and ischemic heart disease: pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) study and future research steps. J Am Coll Cardiol 47 (2006) S66-S71
8. Vassalle C., Petrozzi L., Botto N., Andreassi M.G., and Zucchelli G.C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 256 (2004) 308-315
9. Vassalle C., Botto N., Andreassi M.G., Berti S., and Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis 14 (2003) 213-218
10. Vassalle C., Boni C., Di Cecco P., Ndreu R., and Zucchelli G.C. Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clin Chem Lab Med 44 (2006) 1372-1375
11. Oparil S. Hormones and vasoprotection. Hypertension 33 (1999) 170-176
12. Ide T., Tsutsui H., Ohashi N., Hayashidani S., Suematsu N., Tsuchihashi M., et al. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22 (2002) 438-442
13. Unfer T.C., Conterato G.M., da Silva J.C., Duarte M.M., and Emanuelli T. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta 369 (2006) 73-77
14. Maffei S., Mercuri A., Prontera C., Zucchelli G.C., and Vassalle C. Vasoactive biomarkers and oxidative stress in healthy recent post-menopausal women treated with hormone replacement therapy. Climacteric 9 (2006) 452-458
15. Helmersson J., Mattsson P., and Basu S. Prostaglandin F(2alpha) metabolite and F2-isoprostane excretion in migraine. Clin Sci (Lond) 102 (2002) 39-43
16. Signorelli S.S., Neri S., Sciacchitano S., Pino L.D., Costa M.P., Pennisi G., et al. Duration of menopause and behavior of malondialdehyde, lipids, lipoproteins and carotid wall artery intima-media thickness. Maturitas 39 (2001) 39-42
17. 2α as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 109 (2004) 843-848
18. Stramba-Badiale M., Fox K.M., Priori S.G., Collins P., Daly C., Graham I., et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 27 (2006) 994-1005
19. Ouyang P., Michos E.D., and Karas R.H. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 47 (2006) 1741-1753
20. Marra G., Cotroneo P., Pitocco D., Manto A., Di Leo M.A., Ruotolo V., et al. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 25 (2002) 370-375
21. Garcia-Moll X., Zouridakis E., Cole D., and Kaski J.C. C-Reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J 21 (2000) 1598-1606
22. Haverkate F., Thompson S.G., and Duckert F. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group. Thromb Haemost 73 (1995) 561-567